Bitter Gourd for Human Health, Nutrition, and Value Addition
Authors:
- 19 May 2023
- book chapter
- Published by Springer Nature
- p. 141-177
Abstract
No abstract availableKeywords
This publication has 146 references indexed in Scilit:
- Cucurbitane Triterpenoid fromMomordica charantiaInduces Apoptosis and Autophagy in Breast Cancer Cells, in Part, through Peroxisome Proliferator-Activated ReceptorγActivationEvidence-Based Complementary and Alternative Medicine, 2013
- Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitroPhytomedicine, 2011
- Strategies to improve palatability and increase consumption intentions for Momordica charantia(bitter melon): A vegetable commonly used for diabetes managementNutrition Journal, 2011
- Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammationJournal of Neuroinflammation, 2011
- Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genesBMC Complementary and Alternative Medicine, 2010
- Extraction, Quantification, and Antioxidant Activities of Phenolics from Pericarp and Seeds of Bitter Melons (Momordica charantia) Harvested at Three Maturity Stages (Immature, Mature, and Ripe)Journal of Agricultural and Food Chemistry, 2010
- Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini reviewBritish Journal of Nutrition, 2009
- Lipid lowering effects of Momordica charantia (Bitter Melon) in HIV‐1‐protease inhibitor‐treated human hepatoma cells, HepG2British Journal of Pharmacology, 2006
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001
- Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae)Phytomedicine, 1996